Navigation Links
ScienceDirect to host French-language journals from Elsevier Masson
Date:12/12/2007

Amsterdam, December 12, 2007 Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that 45 French-language medical journals from Elsevier Masson will be available on ScienceDirect beginning January 3, 2008.

The titles, including Feuillets de Radiologie, Journal de Chirurgie and La Press Mdicale, represent a wide range of high-quality journals and complement the 27 ditions Scientifique et Mdicales Elsevier (ESME) titles already hosted on the platform. The importance of this content addition is two-fold: it is a response to growing customer demand in French-speaking territories for French-language content, and it furthers Elseviers local-language publishing program, which is making a wealth of important content accessible globally.

We are always striving to respond positively to customer requests and deliver the content that will help them in their research, said Jay Katzen, Managing Director, Academic & Government Products. The addition of this world-class local-language content meets both of these objectives and ensures that ScienceDirect continues to remain a comprehensive and complete platform.

The 45 titles that will be added date from the early 19th and 20th centuries and have strong ties with some of the most revered French Societies including the French Society of Rheumatology, the French Society of Anaesthesiology and the French Society of Pediatrics. The variety of specialist coverage is notable, with journal subjects ranging from anaesthesiology to pharmacology.

All of the journals to be added consist of high-quality articles, reviews and case reports. In addition, a number of the journals include some abstracts and articles in English. Subscribers will benefit from the current (2008) articles as well as four years in backfiles.

The Elsevier Masson collection on ScienceDirect will evolve with new titles added each year through new launches and acquisition
'/>"/>

Contact: Lauren Hillman
lauren.hillman@fusionpr.com
202-898-2000
Elsevier
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
2. Elsevier journals participate widely in global theme issue on poverty and human development
3. 9 SAGE journals participate in global theme issue on poverty and human development
4. Springer adds Advances in Therapy to journals portfolio
5. Launch of Innovative Journals on Quality and Performance Improvement in Medicine by Dowden Health Media
6. Elsevier launches new journal: Stem Cell Research
7. Elsevier announces new journal on inflammatory bowel diseases
8. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
9. Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...d other cancers are mainly caused by cigarette smo...the risk of cancer occurrence. In order to reduce ...n Tobacco company is in the process of testing //t...h they feel will reduce the carcinogen exposure to...
...ugh, which could eventually lead to a practical an...scientists from the US National Cancer Institute h...man body to produce chemicals that block HIV infec... on the surfaces of the gut and reproductive areas...
...ink has been established between age-related macul...ing the disease process. The finding has been conf...d Chlamydia pneumoniae in the diseased tissue of t...able that the microorganism is associated with chr...
... threat of bird flu in the famous Ranganathittu bi... Bangalore, Karnataka Forest Department today said...from migratory birds. // The Department has taken ...u as it is generally flocked by migratory birds fr...
Other Medicine News:Health News:Genetically modified bacteria to combat HIV 2Health News:Bird flu threat ruled out: Karnataka Forest Department, 2
(Date:10/13/2008)... January 2009 and Final Trial .... 13 /- Neurobiological,Tec...nounced that following a,meeting with the U.S. Foo...TM) (ancrod) Phase 3 clinical program for acute is...d analyze data from its two concurrently,running d...
(Date:10/12/2008)...ewswire-FirstCall/ -- Boston,Scientific Corporatio...alysis,of nearly 7,500 patients from its TAXUS ARR...irm the performance of the TAXUS(R) Express2(TM),P...rld practice. The,two-year pooled ARRIVE data show...s in patients with diabetes as effectively as in p...
(Date:10/10/2008)...ll/ -- Boston Scientific,Corporation (NYSE: BSX )...or,events and press announcements at the Cardiovas... Transcatheter Cardiovascular Therapeutics (TCT),s... 17 in Washington, D.C., Boston Scientific will b...ata on its TAXUS(R) Express2(TM) and second-genera...
(Date:10/9/2008)...mber 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-Fir...ced today the completion of patient enrollment and...to evaluate the safety and,efficacy of its formula...r,the over-the-counter (OTC) market. The Company e...l trial in November 2008. Ibuprofen is an analgesi...
Breaking Medicine Technology:Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Hill Rom to Present at the Citi Healthcare Conference 18778 15th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 18775 15th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 18775 2Met Pro Corporation to Report First Quarter Earnings on May 22 18772 1Met Pro Corporation to Report First Quarter Earnings on May 22 18772 2Met Pro Corporation to Report First Quarter Earnings on May 22 18772 3Mangos Captures 11 HMR Awards 18769 1Mangos Captures 11 HMR Awards 18769 2
Humerus Fracture Brace indications: , Nonoperative treatment of closed humeral shaft fractures , Postoperative treatment of open humeral shaft fractures , Protection of humeral defects , After rem
The FUNCTIONAL ARM BRACE (FAB) was designed to allow immobilization in multiple positions to make it useful as a functional brace in early rehabilitation., ,Far more than an "Elbow ROM Brace" - the
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion
...This simple concept is the cornerstone of our Town...k the heel with our patent-pending Stablelock Syst...t your patient will experience walking in their TS... and supports the posterior aspect of the leg. Thi...
Medicine Products: